Pharmacogenomics in Pulmonary Arterial Hypertension

Stopped study not started not an ACT

Conditions

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension
• PAH WHO Group I

Interventions

• DRUG: Sitaxsentan
• DRUG: Bosentan, Ambrisentan

Sponsor

West Penn Allegheny Health System

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]